Graphite Bio Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Graphite Bio Inc
TickerLENZ
CIK #0001815776
CUSIP52635N103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address279 East Grand Avenue, Suite 430, South San Francisco, CA 94080
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Graphite Bio Inc 2021-03-19 150.7 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001815776] 10-K
[0001815776] 10-Q
[0001815776] 3
[0001815776] 4
[0001815776] 8-K
[0001815776] D
[0001815776] SC 13D
[0001815776] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Lenz Therapeutics Inc [2026-06-26] 0.0
BlackRock Inc Lenz Therapeutics Inc [2026-04-27] 0.0
Squarepoint Ops LLC Lenz Therapeutics Inc [2026-04-08] 0.0
FMR LLC Lenz Therapeutics Inc [2025-11-07] 0.0
BlackRock Inc Lenz Therapeutics Inc [2025-10-17] 0.0
Paradigm Biocapital Advisors LP Lenz Therapeutics Inc [2025-03-27] 0.0
Ridgeback Capital Investments LP Lenz Therapeutics Inc [2024-07-29] 7.2
RA Capital Management LP Lenz Therapeutics Inc [2024-03-28] 16.6
Alpha Wave Ventures GP Ltd Lenz Therapeutics Inc [2024-03-28] 14.1
Point72 Asset Management LP Lenz Therapeutics Inc [2024-03-25] 3.4
Tang Capital Partners LP Graphite Bio Inc [2024-02-05] 5.4
EcoR1 Capital LLC Graphite Bio Inc [2022-11-18] 0.8
Porteus Matthew Graphite Bio Inc [2022-02-14] 6.1
FMR LLC Graphite Bio Inc [2021-10-12] 0.0
Samsara Biocapital LP Graphite Bio Inc [2021-07-09] 12.7
Versant Venture Capital VI LP Graphite Bio Inc [2021-07-09] 11.0
Form 3/4/5 Filer 2011 - 2026
Scheiner Zachary
LENZ Therapeutics Inc
McCollum James W
George Jeffrey P
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II LP
RA Capital Management LP
Kolchinsky Peter
Thunen Shelley B
Drapkin Kimberlee C
Guerard Frederic
Chevallard Daniel R
Schimmelpennink Evert B
Odrich Marc
Olsson Shawn
Versant Ventures VII GP LP
Versant Vantage II LP
Versant Venture Capital VII LP
Versant Ventures VI GP LP
Versant Vantage II GP LP
Versant Ventures VI GP-GP LLC
Versant Vantage II GP-GP LLC
Versant Venture Capital VI LP
Versant Ventures VII GP-GP LLC
Lunate Holding RSC Ltd
Alpha Wave Global LP
Chimera Investment LLC
Alpha Wave Ventures GP Ltd
Carlo Rizzuto
Hege Kristen
Shah Smital
Bassan Abraham
Jerel Davis
Jimenez Joseph
Karsen Perry A
Porteus Matthew
Viney Joanne L
Young Alethia
Lehrer-Graiwer Joshua
EcoR1 Capital LLC
Akkaraju Srinivas
Samsara BioCapital LP
Gutry Phil
436 LP
Stultz Katherine V
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Chevallard Daniel R
Common Stock
2026-03-27 Buy 7,500 $8.57 64,275
Schimmelpennink Evert B
Common Stock
2026-03-27 Buy 28,089 $8.95 251,397
George Jeffrey P
Common Stock
2026-03-27 Buy 5,592 $8.92 49,881
Odrich Marc
Stock Option (right to buy) · derivative
2026-01-02 Grant 84,200 $0.00
Chevallard Daniel R
Restricted Stock Unit · derivative
2026-01-02 Grant 14,000 $0.00
Olsson Shawn
Stock Option (right to buy) · derivative
2026-01-02 Grant 84,200 $0.00
Schimmelpennink Evert B
Stock Option (right to buy) · derivative
2026-01-02 Grant 358,100 $0.00
Chevallard Daniel R
Stock Option (right to buy) · derivative
2026-01-02 Grant 84,200 $0.00
Olsson Shawn
Restricted Stock Unit · derivative
2026-01-02 Grant 14,000 $0.00
Odrich Marc
Restricted Stock Unit · derivative
2026-01-02 Grant 14,000 $0.00
Olsson Shawn
Common Stock
2025-11-17 Sell 4,212 $25.74 108,417
Olsson Shawn
Common Stock
2025-11-17 Sell 5,788 $26.37 152,630
Olsson Shawn
Stock Option (right to buy) · derivative
2025-11-17 Option exercise 10,000 $0.00
Olsson Shawn
Common Stock
2025-11-17 Option exercise 10,000 $2.08 20,800
McCollum James W
Common Stock
2025-11-07 Buy 10,500 $22.79 239,295
Chevallard Daniel R
Common Stock
2025-11-07 Buy 2,178 $22.76 49,571
Chevallard Daniel R
Common Stock
2025-11-07 Buy 20 $22.71 454
Versant Ventures VII GP LP +8
Common Stock
2025-09-30 Sell 83,066 $46.41 3,855,093
Versant Ventures VII GP LP +8
Common Stock
2025-09-30 Sell 34,405 $45.35 1,560,267
Versant Ventures VII GP LP +8
Common Stock
2025-09-30 Sell 49,701 $45.35 2,253,940
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 147 33,324,847
2025-12-31 162 34,210,444
2025-09-30 166 29,033,950
2025-06-30 116 25,116,649
2025-03-31 107 20,733,264
2024-12-31 96 19,008,914
2024-09-30 79 18,297,188
2024-06-30 66 18,918,982
2024-03-31 57 16,286,621
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 70,728 70,728
Alaska Retirement Management Board [2026-06-30] SOLE 37,159 37,159
BFSG LLC [2026-06-30] SOLE 0 635
Farther Finance Advisors LLC [2026-06-30] SOLE 0 595
Gamma Investing LLC [2026-06-30] DFND 486 486
IFP Advisors LLC [2026-06-30] SOLE 392 392
True Wealth Design LLC [2026-06-30] SOLE 0 224
Corecap Advisors LLC [2026-06-30] SOLE 0 164
Ares Financial Consulting LLC [2026-06-30] SOLE 19 19
Fortitude Family Office LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com